With respect to CD4 T cells, Tim-3 was only expressed on a small fraction of the circulating CD4 T cells in healthy individuals, with slightly higher levels of circulating Tim-3+ CD4 T cells observed in HCC patients (Figure 1A and 1B). This evidence concerns the gene HAVCR2 and hepatocellular carcinoma.